Brief: WuXi Biologics Announces FY Revenue Of RMB17,034.3 Mln

WuXi Biologics (Cayman)

26/03/2024 12:05

Mar 26 (Reuters) - WuXi Biologics FY revenue RMB 17,034.3 million.
* FY net income RMB 3,570.6 million
* FY gross profit RMB 6,827.9 million
* FY gross margin 40.1%
* FY adjusted net income RMB 4,698.9 million
* FY pretax profit RMB 4,173.8 million